Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adult neurogenesis: New neurons, new opportunities.

Cell stem cell·2026

Same author

Apolipoprotein A1 reduces blood-spinal cord barrier leakage, improves astrocytic coverage, and enhances motor neuron survival to restore the neurovascular unit in ALS mice.

Frontiers in aging neuroscience·2026

Same author

Functionalized graphene oxide triggers the neurogenic potential on neuroblastoma cell line (SH-SY5Y) and human amniotic fluid stem cells (hAFSCs).

Colloids and surfaces. B, Biointerfaces·2025

Same author

Ischemic Penumbra Protection: Beyond Brains or Not.

MedComm·2025

Same author

Evaluation of the gastrotolerability of ketoprofen, lysine, and gabapentin co-crystal administration in an in vitro model of gastric epithelium: a proteomic update.

PloS one·2025

Same author

Stem Cells Run Like Clockwork for Stroke Therapeutics.

Stem cell reviews and reports·2025

Same journal

Brent A. Reynolds, pioneer of adult neural stem cell biology.

Stem cells (Dayton, Ohio)·2026

Same journal

CircVapa promotes the abnormal differentiation of small intestinal epithelial stem cells in diabetic state.

Stem cells (Dayton, Ohio)·2026

Same journal

Transforming Growth Factor beta-2 (TGFβ2) Drives Trabecular Meshwork Progenitor Cell Differentiation Through SMAD2/3 Signalling.

Stem cells (Dayton, Ohio)·2026

Same journal

Circular RNA circEGFR overexpression attenuates chemosensitivity and enhances cancer stemness via targeting IGF2BP2/SOX2 in breast cancer cells.

Stem cells (Dayton, Ohio)·2026

Same journal

Regeneration of the mammalian brain: a relic of evolution?

Stem cells (Dayton, Ohio)·2026

Same journal

Mitochondrial transfer technologies with molecular insights into clinical applications.

Stem cells (Dayton, Ohio)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 14, 2026

Author Spotlight: Decoding Mitochondrial Aging

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

Stem cells enhance mitochondrial function in experimental Huntington's disease.

Francesco D'Egidio¹, Napasiri Putthanbut², Michaela Starahs³

¹Department of Life, Health and Environmental Sciences, University of L'Aquila 67100, L'Aquila, Italy.

Stem Cells (Dayton, Ohio)

|April 12, 2026

Summary

This summary is machine-generated.

Mesenchymal stem cells (MSCs) therapy improved mitochondrial function and reduced inflammation in Huntington

Keywords:

Huntington’s disease cell-free therapy mesenchymal stem cells mitochondrial transfer secretome

More Related Videos

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Published on: October 10, 2025

Flow Cytometric Analysis of Multiple Mitochondrial Parameters in Human Induced Pluripotent Stem Cells and Their Neural and Glial Derivatives

Flow Cytometric Analysis of Multiple Mitochondrial Parameters in Human Induced Pluripotent Stem Cells and Their Neural and Glial Derivatives

Published on: November 8, 2021

Related Experiment Videos

Last Updated: Apr 14, 2026

Author Spotlight: Decoding Mitochondrial Aging

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Published on: October 10, 2025

Flow Cytometric Analysis of Multiple Mitochondrial Parameters in Human Induced Pluripotent Stem Cells and Their Neural and Glial Derivatives

Flow Cytometric Analysis of Multiple Mitochondrial Parameters in Human Induced Pluripotent Stem Cells and Their Neural and Glial Derivatives

Published on: November 8, 2021

Area of Science:

Neuroscience
Cell Biology
Genetics

Background:

Huntington's Disease (HD) involves CAG triplet expansion in the HTT gene, leading to mutant Huntingtin protein.
Mutant Huntingtin impairs mitochondrial dynamics, reducing fusion and increasing fission.
Mesenchymal stem cells (MSCs) offer therapeutic potential via mitochondria transfer and secretomes.

Purpose of the Study:

To investigate the therapeutic effects of MSCs on Huntington's Disease models.
To assess MSCs' impact on mitochondrial function, neuroinflammation, and neuronal markers in HD models.

Main Methods:

Co-culture of quinolinic acid-lesioned neuro-2a (QA-N2a) cells and 50 CAG repeat Huntington's Disease (HD) neurons with human umbilical cord-derived MSCs.
Immunocytochemistry to analyze GABA, Substance P, and mitochondrial proteins.
Western Blot to evaluate inflammation and mitochondrial function-related proteins.

Main Results:

MSC co-culture restored GABA and Substance P expression in QA-N2a cells.
HD neurons showed increased mitochondrial abundance, intensity, and dendritic distribution after MSC co-culture.
MSCs promoted mitochondrial fusion (increased MFN2, OPA1) and reduced inflammation markers (IL-6, TNF-α, MMP9, p-NFkB).

Conclusions:

MSCs effectively alleviate Huntington's Disease pathology in vitro.
MSC therapy restores mitochondrial activity and potentially suppresses neuroinflammation.
This study highlights MSCs as a promising therapeutic strategy for Huntington's Disease.